CHAD M ROBINS Insider Trading $ADPT Adaptive Biotechnologies Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHAD M ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHAD M ROBINS. CHAD M ROBINS is CEO and Chairman in Adaptive Biotechnologies Corp ($ADPT).
CHAD M ROBINS in Adaptive Biotechnologies Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CHAD M ROBINS: CEO and Chairman
Holdings: 1,761,861 shares
Latest Transaction: Apr 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHAD M ROBINS in Adaptive Biotechnologies Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.78 | 100 | 4,378 | 1,748,461 | 1.7 M to 1.7 M (-0.01 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.00 | 1,957 | 84,151 | 1,748,561 | 1.8 M to 1.7 M (-0.11 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.04 | 2,943 | 123,724 | 1,750,518 | 1.8 M to 1.8 M (-0.17 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.45 | 1,100 | 45,595 | 1,753,461 | 1.8 M to 1.8 M (-0.06 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.61 | 3,900 | 158,379 | 1,754,561 | 1.8 M to 1.8 M (-0.22 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.08 | 1,200 | 51,696 | 1,758,461 | 1.8 M to 1.8 M (-0.07 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.48 | 2,200 | 93,456 | 1,759,661 | 1.8 M to 1.8 M (-0.12 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.08 | 1,600 | 65,728 | 1,761,861 | 1.8 M to 1.8 M (-0.09 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.48 | 100 | 4,248 | 1,763,461 | 1.8 M to 1.8 M (-0.01 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.96 | 4,900 | 205,604 | 1,763,561 | 1.8 M to 1.8 M (-0.28 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.78 | 470 | 20,577 | 1,768,461 | 1.8 M to 1.8 M (-0.03 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.81 | 2,604 | 111,477 | 1,768,931 | 1.8 M to 1.8 M (-0.15 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.90 | 1,926 | 80,699 | 1,771,535 | 1.8 M to 1.8 M (-0.11 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.25 | 1,804 | 81,631 | 1,773,461 | 1.8 M to 1.8 M (-0.10 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.03 | 1,295 | 57,019 | 1,775,265 | 1.8 M to 1.8 M (-0.07 %) |
| Mar 19 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.22 | 1,901 | 82,161 | 1,776,560 | 1.8 M to 1.8 M (-0.11 %) |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | A | 43.68 | 171,703 | 7,499,987 | 171,703 | |
| Mar 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Grant | A | 0.00 | 68,681 | 0 | 1,778,461 | 1.7 M to 1.8 M (+4.02 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 64.27 | 1,200 | 77,124 | 1,709,780 | 1.7 M to 1.7 M (-0.07 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.25 | 1,204 | 76,153 | 1,710,980 | 1.7 M to 1.7 M (-0.07 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.56 | 6,801 | 425,471 | 1,712,184 | 1.7 M to 1.7 M (-0.40 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.51 | 795 | 48,900 | 1,718,985 | 1.7 M to 1.7 M (-0.05 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.23 | 4,160 | 263,037 | 1,719,780 | 1.7 M to 1.7 M (-0.24 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.07 | 5,840 | 362,489 | 1,723,940 | 1.7 M to 1.7 M (-0.34 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.20 | 2,686 | 167,069 | 1,729,780 | 1.7 M to 1.7 M (-0.16 %) |
| Feb 10 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.40 | 7,314 | 449,080 | 1,732,466 | 1.7 M to 1.7 M (-0.42 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.83 | 2,300 | 133,009 | 1,739,780 | 1.7 M to 1.7 M (-0.13 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.32 | 4,300 | 246,476 | 1,742,080 | 1.7 M to 1.7 M (-0.25 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 55.94 | 2,800 | 156,632 | 1,746,380 | 1.7 M to 1.7 M (-0.16 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 55.01 | 600 | 33,006 | 1,749,180 | 1.7 M to 1.7 M (-0.03 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.72 | 1,875 | 111,975 | 1,749,780 | 1.8 M to 1.7 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.79 | 3,246 | 190,832 | 1,751,655 | 1.8 M to 1.8 M (-0.18 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 57.71 | 2,000 | 115,420 | 1,754,901 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 56.26 | 1,000 | 56,260 | 1,756,901 | 1.8 M to 1.8 M (-0.06 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 54.63 | 1,879 | 102,650 | 1,757,901 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 65.23 | 100 | 6,523 | 1,759,780 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 64.52 | 3,526 | 227,498 | 1,759,880 | 1.8 M to 1.8 M (-0.20 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.63 | 2,524 | 160,602 | 1,763,406 | 1.8 M to 1.8 M (-0.14 %) |
| Jan 28 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.51 | 3,850 | 240,664 | 1,765,930 | 1.8 M to 1.8 M (-0.22 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 71.14 | 100 | 7,114 | 1,769,780 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 21 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 70.42 | 8,300 | 584,486 | 1,769,880 | 1.8 M to 1.8 M (-0.47 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 49,560 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 66,240 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 82,920 | |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.54 | 900 | 43,686 | 1,778,180 | 1.8 M to 1.8 M (-0.05 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.75 | 4,360 | 208,190 | 1,779,080 | 1.8 M to 1.8 M (-0.24 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.69 | 3,773 | 176,161 | 1,783,440 | 1.8 M to 1.8 M (-0.21 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.60 | 7,647 | 348,703 | 1,787,213 | 1.8 M to 1.8 M (-0.43 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.52 | 13,480 | 654,050 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.64 | 2,000 | 95,280 | 1,791,660 | 1.8 M to 1.8 M (-0.11 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 1,200 | 56,016 | 1,793,660 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.68 | 5,633 | 262,948 | 1,778,180 | 1.8 M to 1.8 M (-0.32 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.84 | 11,047 | 506,394 | 1,783,813 | 1.8 M to 1.8 M (-0.62 %) |
| Nov 19 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 24,260 | 8,006 | 99,600 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 123,860 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 18,280 | 6,032 | 173,860 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 51.37 | 1,400 | 71,918 | 1,778,180 | 1.8 M to 1.8 M (-0.08 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 50.56 | 22,860 | 1,155,802 | 1,779,580 | 1.8 M to 1.8 M (-1.27 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 24,260 | 8,006 | 1,802,440 | 1.8 M to 1.8 M (+1.36 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 50.20 | 48,800 | 2,449,760 | 1,778,180 | 1.8 M to 1.8 M (-2.67 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 49.40 | 1,200 | 59,280 | 1,826,980 | 1.8 M to 1.8 M (-0.07 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,828,180 | 1.8 M to 1.8 M (+2.81 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 49.83 | 8,102 | 403,723 | 1,778,180 | 1.8 M to 1.8 M (-0.45 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.99 | 10,178 | 498,620 | 1,786,282 | 1.8 M to 1.8 M (-0.57 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 18,280 | 6,032 | 1,796,460 | 1.8 M to 1.8 M (+1.03 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 194,640 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 211,320 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 228,000 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.13 | 8,580 | 395,795 | 1,778,180 | 1.8 M to 1.8 M (-0.48 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.28 | 8,100 | 366,768 | 1,786,760 | 1.8 M to 1.8 M (-0.45 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.26 | 14,080 | 637,261 | 1,778,180 | 1.8 M to 1.8 M (-0.79 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.48 | 2,600 | 115,648 | 1,792,260 | 1.8 M to 1.8 M (-0.14 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 194,640 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.26 | 400 | 19,304 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 211,320 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.46 | 5,100 | 242,046 | 1,778,580 | 1.8 M to 1.8 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 228,000 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.45 | 5,000 | 232,250 | 1,738,680 | 1.7 M to 1.7 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.13 | 8,580 | 395,795 | 1,778,180 | 1.8 M to 1.8 M (-0.48 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.47 | 6,180 | 281,005 | 1,788,680 | 1.8 M to 1.8 M (-0.34 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.28 | 8,100 | 366,768 | 1,786,760 | 1.8 M to 1.8 M (-0.45 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.26 | 14,080 | 637,261 | 1,778,180 | 1.8 M to 1.8 M (-0.79 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.48 | 2,600 | 115,648 | 1,792,260 | 1.8 M to 1.8 M (-0.14 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.26 | 400 | 19,304 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.46 | 5,100 | 242,046 | 1,778,580 | 1.8 M to 1.8 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.45 | 5,000 | 232,250 | 1,738,680 | 1.7 M to 1.7 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.47 | 6,180 | 281,005 | 1,788,680 | 1.8 M to 1.8 M (-0.34 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 244,680 | |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 261,360 | |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 278,040 | |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | S | 38.43 | 9,005 | 346,062 | 1,778,180 | 1.8 M to 1.8 M (+0.51 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.50 | 6,774 | 254,025 | 1,787,185 | 1.8 M to 1.8 M (-0.38 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 36.80 | 901 | 33,157 | 1,793,959 | 1.8 M to 1.8 M (-0.05 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.96 | 2,000 | 75,920 | 1,778,180 | 1.8 M to 1.8 M (-0.11 %) |
| Aug 12 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.40 | 9,743 | 364,388 | 1,780,180 | 1.8 M to 1.8 M (-0.54 %) |